81 related articles for article (PubMed ID: 3468880)
1. The prognostic implication of clinical and histological features in Ph1+ chronic myelocytic leukaemia (CML).
Thiele J; Fohlmeister I; Vonneguth B; Zankovich R; Fischer R
Anticancer Res; 1986; 6(6):1401-9. PubMed ID: 3468880
[TBL] [Abstract][Full Text] [Related]
2. Prognostic value of chromosomal findings in Ph1-positive chronic myelocytic leukemia.
Sakurai M; Hayata I; Sandberg AA
Cancer Res; 1976 Feb; 36(2 Pt 1):313-8. PubMed ID: 1063061
[TBL] [Abstract][Full Text] [Related]
3. Primary myelofibrosis-osteomyelosclerosis (agnogenic myeloid metaplasia): correlation of clinical findings with bone marrow histopathology and prognosis.
Thiele J; Steinberg T; Zankovich R; Fischer R
Anticancer Res; 1989; 9(2):429-35. PubMed ID: 2751268
[TBL] [Abstract][Full Text] [Related]
4. Clinical and prognostic features of Nigerians with chronic myeloid leukemia.
Boma PO; Durosinmi MA; Adediran IA; Akinola NO; Salawu L
Niger Postgrad Med J; 2006 Mar; 13(1):47-52. PubMed ID: 16633379
[TBL] [Abstract][Full Text] [Related]
5. Intensive treatment of patients age 60 years and older with de novo acute myeloid leukemia: analysis of prognostic factors.
Stasi R; Venditti A; Del Poeta G; Aronica G; Dentamaro T; Cecconi M; Stipa E; Scimò MT; Masi M; Amadori S
Cancer; 1996 Jun; 77(12):2476-88. PubMed ID: 8640696
[TBL] [Abstract][Full Text] [Related]
6. Prognostic features at diagnosis of chronic myeloid leukaemia with special emphasis on histological parameters.
Thiele J; Thienel C; Zankovich R; Fischer R
Med Oncol Tumor Pharmacother; 1988; 5(1):49-60. PubMed ID: 3163405
[TBL] [Abstract][Full Text] [Related]
7. Prognostic impact of acute myeloid leukemia classification. Importance of detection of recurring cytogenetic abnormalities and multilineage dysplasia on survival.
Arber DA; Stein AS; Carter NH; Ikle D; Forman SJ; Slovak ML
Am J Clin Pathol; 2003 May; 119(5):672-80. PubMed ID: 12760285
[TBL] [Abstract][Full Text] [Related]
8. Detection of risk groups in myelodysplastic syndromes. A multicenter study.
Belli C; Acevedo S; Bengio R; Arrossagaray G; Watman N; Rossi N; García J; Flores G; Goldztein S; Larripa I
Haematologica; 2002 Jan; 87(1):9-16. PubMed ID: 11801460
[TBL] [Abstract][Full Text] [Related]
9. Prognostic factors in chronic granulocytic leukemia. A study of 798 cases.
Jacquillat C; Chastang C; Tanzer J; Brière J; Weil M; Pereira-Neto M; Gemon-Auclerc MF; Schaison G; Domingo A; Boiron M; Bernard J
Boll Ist Sieroter Milan; 1978 Jul; 57(3):237-46. PubMed ID: 282895
[TBL] [Abstract][Full Text] [Related]
10. The syndrome of idiopathic myelofibrosis. A clinicopathologic review with emphasis on the prognostic variables predicting survival.
Varki A; Lottenberg R; Griffith R; Reinhard E
Medicine (Baltimore); 1983 Nov; 62(6):353-71. PubMed ID: 6633248
[TBL] [Abstract][Full Text] [Related]
11. Clinical relevance of bone marrow fibrosis and CD34-positive cell clusters in primary myelodysplastic syndromes.
Della Porta MG; Malcovati L; Boveri E; Travaglino E; Pietra D; Pascutto C; Passamonti F; Invernizzi R; Castello A; Magrini U; Lazzarino M; Cazzola M
J Clin Oncol; 2009 Feb; 27(5):754-62. PubMed ID: 19103730
[TBL] [Abstract][Full Text] [Related]
12. Prospective confirmation of a prognostic classification for Ph+ chronic myeloid leukaemia. The Italian Cooperative Study Group on Chronic Myeloid Leukaemia.
Br J Haematol; 1988 Aug; 69(4):463-6. PubMed ID: 3165671
[TBL] [Abstract][Full Text] [Related]
13. Comparison of five prognostic scoring systems, the French-American-British (FAB) and World Health Organization (WHO) classifications in patients with myelodysplastic syndromes: Results of a single-center analysis.
Müller-Berndorff H; Haas PS; Kunzmann R; Schulte-Mönting J; Lübbert M
Ann Hematol; 2006 Aug; 85(8):502-13. PubMed ID: 16715299
[TBL] [Abstract][Full Text] [Related]
14. [Bone-marrow biopsy in chronic myeloid leukemia. Significance during development].
Devred C; Bentata J; Diebold J; Bernadou A; Bilski-Pasquier G
Sem Hop; 1977 Jan; 53(2):125-31. PubMed ID: 189425
[TBL] [Abstract][Full Text] [Related]
15. The value of bone marrow biopsy in chronic myeloid leukaemia.
Seewann HL; Lehnert M; Jüttner F
Haematologia (Budap); 1983; 16(1-4):67-72. PubMed ID: 6592124
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of bone marrow reticulin fibres in idiopathic myelofibrosis: evaluation of clinicopathological parameters in a scoring system.
Iványi JL; Mahunka M; Papp A; Kiss A; Telek B
Haematologia (Budap); 1994; 26(2):75-86. PubMed ID: 7890265
[TBL] [Abstract][Full Text] [Related]
17. A new prognostic score for patients with acute myeloid leukemia based on cytogenetics and early blast clearance in trials of the German AML Cooperative Group.
Haferlach T; Kern W; Schoch C; Schnittger S; Sauerland MC; Heinecke A; Büchner T; Hiddemann W;
Haematologica; 2004 Apr; 89(4):408-18. PubMed ID: 15075074
[TBL] [Abstract][Full Text] [Related]
18. Spleen size and chromosome analysis as prognostic factors in chronic myelogenous leukemia.
Collins RK; Jackson JF; Morrison FS; Meydrech EF
South Med J; 1979 Jun; 72(6):642-4, 651. PubMed ID: 287200
[TBL] [Abstract][Full Text] [Related]
19. [Comparative clinical and histological investigations in chronic myeloid leukaemias ].
Seewann HL; Jüttner F; Vykoupil KF
Wien Klin Wochenschr; 1982 May; 94(10):270-2. PubMed ID: 6957071
[TBL] [Abstract][Full Text] [Related]
20. Retrospective analysis of 23 cases with peripheral T-cell lymphoma, unspecified: clinical characteristics and outcome.
Zaja F; Russo D; Silvestri F; Fanin R; Damiani D; Infanti L; Salmaso F; Mariuzzi L; Di Loreto C; Baccarani M
Haematologica; 1997; 82(2):171-7. PubMed ID: 9175321
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
